Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy
SGLT2 inhibitors have an insulin-independent mechanism of action leading to increasing glycosuria and lowering plasma glucose concentration, which results in cardiovascular and renal benefits shown in various studies. Other benefits include improvements in hyperglycemia, decreased fluid retention, r...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Sonali Sharma on behalf of Rajasthan University of Health Sciences
2023-07-01
|
Series: | RUHS Journal of Health Sciences |
Subjects: | |
Online Access: | https://ruhsjhs.in/articleDetails.php?artid=TXprPQ== |